未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Prevalence, Treatment Patterns, and Characteristics of US Adults with Confirmed or at Risk for Growth Hormone Deficiency Hoffman, Andrew R.; Raveendran, Subhara; Manjelievskaia, Janna; Komirenko, Allison S.; Winer, Isabelle; Cheng, Jennifer; Bonafede, Machaon; Winer-Jones, Jessamine P.; Miner, Paul; Smith, Alden R. 分享 收藏
分享 收藏
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19-related Hospitalizations and Medical Encounters Among Adults in the United States 含有2023-2024 Omicron XBB.1.5的mRNA新型冠状病毒肺炎疫苗 (mRNA-1273.815) 在预防美国成年人COVID-19-related住院和医疗接触中的有效性 Kopel, Hagit; Araujo, Andre B.; Bogdanov, Alina; Zeng, Ni; Winer, Isabelle; Winer-Jones, Jessamine P.; Lu, Tianyi; Marks, Morgan A.; Bonafede, Machaon; Nguyen, Van Hung; Martin, David; Mansi, James A. 分享 收藏
分享 收藏
Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United States 双价 (原始/Omicron BA.4/BA.5) mRNA新型冠状病毒肺炎疫苗mRNA-1273.222和BNT162b2双价在美国患有基础疾病的成年人中的比较有效性 Kopel, Hagit; Nguyen, Van Hung; Bogdanov, Alina; Winer, Isabelle; Boileau, Catherine; Ducruet, Thierry; Zeng, Ni; Winer-Jones, Jessamine P.; Esposito, Daina B.; Bausch-Jurken, Mary; Beck, Ekkehard; Bonafede, Machaon; Mansi, James A. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏